Predictive BioSciences Lands $21,750,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2ed2f836-8b50-4d54-87cb-7def05b1cfec&Preview=1 -
Date
10/16/2008 -
Company Name
Predictive BioSciences -
Mailing Address
128 Spring Street, 400 Level, B Annex Lexington, MA 02421 -
Company Description
Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a $10 million Series A financing, the company was jointly founded by leading healthcare investors, experienced entrepreneurs, and internationally-renowned scientists in the areas of tumor growth, tumor angiogenesis, and cancer markers. Predictive Biosciences possesses an extensive IP portfolio – including 18 issued US patents – and deep in-house expertise in proteomics, diagnostics, oncology, and tumor biomarkers. -
Website
http://www.predictivebiosci.com -
Transaction Type
Venture Equity -
Transaction Amount
$21,750,000 -
Transaction Round
Series B -
Proceeds Purposes
Predictive intends to use the proceeds from the Series B financing to complete current clinical validation studies and initiate multi-center clinical trials. -
M&A Terms
-
Venture Investor
New Enterprise Associates -
Venture Investor
Kaiser Permanente Ventures -
Venture Investor
Flybridge Capital Partners -
Venture Investor
Highland Capital Partners
